Western blot analysis was performed as described previously (14) . Anti-MERS-CoV-178 nsp1 peptide antibody, generated by immunizing rabbits with the synthetic peptide 179 (RKYGRGGYHYTPFHYERD), anti-myc mouse monoclonal antibody (MAb) (Millipore) 180 and anti-V5 rabbit MAb (Abcam) were used as primary antibodies. Goat anti-mouse IgG-181 HRP and goat anti-rabbit IgG-HRP (Santa Cruz Biotech) were used as secondary 182 antibodies.
183
Co-sedimentation analysis 184 Cell lysates were prepared in a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 5 mM 185 MgCl 2 , 100 mM KCl, 1% (v/v) Triton-X-100, 2 mM dithiothreitol (DTT), 100 μg/μl 186 cycloheximide and 0.5 mg/μl heparin. The lysates were applied onto a 10% to 40% 187 continuous sucrose gradient prepared in the same buffer and centrifuged at 38,000 rpm 188 in a Beckman SW41 rotor at 4°C for 3 h. After fractionation, the proteins in each fraction 189 were precipitated with trichloroacetic acid/acetone and detected by Western blot 9 analysis. Total RNAs were also extracted from the fractions and the ribosomal RNAs 191 (rRNAs) were visualized by staining with ethidium bromide. Fernando, CA) to completely inactivate MERS-CoV infectivity. After quickly thawing the 206 frozen cells, cell lysates were prepared by incubating the cells in buffer 1 (25 mM 207 HEPES, pH 7.9, 5 mM KCl, 0.5 mM MgCl 2 , 1 mM DTT, and 0.5% NP-40 supplemented 208 with a protease inhibitor cocktail) for 15 min at 4 o C. Following centrifugation at 5,000 rpm 209 for 5 min, supernatants were collected and designated as the cytoplasmic fractions. The 210 pellets were incubated in buffer 2 (25 mM HEPES, pH 7.9, 5 mM KCl, 0.5 mM MgCl 2 , 1 211 mM DTT, and 0.25% NP-40 supplemented with a protease inhibitor cocktail) for 10 min 212 at 4 o C. After centrifugation, the pellets were collected and designated as the nuclear 213 fractions (28). Essentially, the same method was used to prepare the cytoplasmic and 214 nuclear fractions from cells expressing MERS-CoV nsp1, except that the 60 Co irradiation 215 step was omitted.
216

Generation of RVFV-like particles (RVFV VLPs)
217
RVFV VLPs, carrying an RNA encoding the rLuc gene (LNCR-rLuc RNA) flanked by the 218 3' and 5' noncoding regions of RVFV L RNA, were prepared as described previously 219 (29) . Briefly, BSR-T7/5 cells (30), stably expressing T7 RNA polymerase, were co- 
313
A SARS-CoV nsp1 mutant carrying alanine substitutions of two charged amino 314 acid residues, R125 and K126, exposed on the surface of nsp1 (33), retained its ability 315 to inhibit translation but lacked the endonucleolytic RNA cleavage function (19). As the 
327
CoV nsp1 was lower than that encoding MERS-CoV nsp1-CD (Fig. 2C, second panel) ,
328
suggesting that MERS-CoV nsp1 targeted its own template mRNA for degradation and 329 that MERS-CoV nsp1-CD lacked the ability to degrade mRNAs. Furthermore, MERS-
330
CoV nsp1-CD expression did not cause a reduction in the amounts of GAPDH and β-331 actin mRNAs in the presence of ActD, suggesting that MERS-CoV nsp1-CD lacked the 332 ability to induce the degradation of pre-existing host mRNAs (Fig. 2B) . These data point 333 towards MERS-CoV nsp1-induced mRNA cleavage as the trigger that results in mRNA 334 degradation.
335
Like SARS-CoV nsp1, MERS-CoV nsp1 also strongly inhibited the rLuc reporter 336 activity (Fig. 2C, fourth panel) . It is important to note that MERS-CoV nsp1-CD also 337 inhibited the rLuc reporter activity, albeit to a lesser extent than MERS-CoV nsp1 ( Fig. 
338
2C, fourth panel). Furthermore, metabolic radiolabeling experiments showed that MERS-
339
CoV nsp1-CD expression inhibited host protein synthesis but the extent of inhibition was 340 lower than that induced by MERS-CoV nsp1 ( Fig. 2A) . These data clearly demonstrated 341 that the RNA cleavage function of MERS-CoV nsp1 contributed to, but was not required 342 for the ability of MERS-CoV nsp1 to inhibit host protein synthesis.
343
Taken together, these data suggest that MERS-CoV nsp1 possesses two distinct 
381
or Pol III-driven transcripts (Fig. 4A) . A minor band migrating below the Pol III-driven 382 transcript was also observed in a published study using the same plasmid (21). The 383 source of this band is unknown. These data suggested that like SARS-CoV nsp1,
384
MERS-CoV nsp1 also targets RNAs that are translationally competent for degradation. co-sediment with the 40S subunit, suggesting that unlike SARS-CoV nsp1, MERS-CoV nsp1 does not associate tightly with the 40S subunit and uses a different strategy to gain 399 access to translationally-competent mRNAs (Fig. 4B) . 
412
Intracellular RNAs were also extracted at 24 h post-transfection and subjected to 413 Northern blot analysis. As expected, SARS-CoV nsp1 strongly inhibited the reporter 414 gene activity and induced the degradation of rLuc mRNA (Fig. 5A ). MERS-CoV nsp1 415 also strongly inhibited the reporter gene activity and induced the degradation of rLuc 416 mRNA ( Fig 5A) , which is consistent with our data in Fig. 2 that showed the inhibition of 417 host protein synthesis and induction of reporter mRNA cleavage and degradation by 418 MERS-CoV nsp1. MERS-CoV nsp1-CD did not promote the degradation of rLuc mRNA, 419 but inhibited the reporter gene activity, albeit to a slightly lesser extent than MERS-CoV 420 nsp1, further confirming that MERS-CoV nsp1-CD can inhibit translation without inducing 421 mRNA cleavage (Fig. 5A) . Collectively, these data unambiguously demonstrated that 422 MERS-CoV nsp1 inhibited the translation and induced the degradation of reporter mRNAs as well as cellular mRNAs that are transcribed in the nucleus and transported to 424 the cytoplasm (Figs. 2, 4A and 5A ).
425
To examine the effect of MERS-CoV nsp1 on the translation of exogenous 426 mRNAs introduced directly into the cytoplasm, 293 cells were electroporated with a 427 reporter mRNA, GLA, carrying the 5' UTR of rabbit β-globin mRNA and the rLuc gene 
443
CoV nsp1-CD, which could possibly be due to differences in the inherent stability of the 444 two proteins (Fig. 5B ). We obtained similar results using a different reporter mRNA, ALA, Figs. 2A, B) . These data suggested that the inhibitory activity of MERS-CoV nsp1 on 563 nucleus-derived mRNAs is not exclusively restricted to newly-synthesized mRNAs and 564 can also target pre-existing nuclear-transcribed mRNAs in the cytoplasm. The activity of 565 MERS-CoV nsp1 was directed towards different nuclear-transcribed mRNAs, including 566 endogenous host mRNAs and plasmid-driven reporter mRNAs. Eukaryotic mRNAs that 567 are transcribed in the nucleus are transported to the cytoplasm in the form of an mRNP 568 complex carrying RNA-binding proteins that regulate mRNA translation in response to 569 developmental, physiological and environmental signals (39). We speculate that MERS-
570
CoV nsp1 selectively targets nucleus-derived mRNAs, by binding to one of the mRNA-571 binding proteins that form the host mRNP complex, and inhibits the expression of host 572 genes.
573
MERS-CoV nsp1 did not inhibit the translation of exogenous mRNAs, including 574 MERS-CoV-like mRNA, that were introduced directly into the cytoplasm (Fig. 5 ).
575
Furthermore, MERS-CoV nsp1 did not affect the translation and stability of a virus-like 576 mRNA synthesized in the cytoplasm (Fig. 6 ). These data have important implications for 
